# Cancer Deaths: Sourced Figures for Impact Projections ## Global Cancer Mortality **2022 Global cancer deaths:** 9.7 million (reported, GLOBOCAN 2022 from IARC: https://gco.iarc.who.int/). Denominator: all 185 countries. **2040 Projected annual cancer deaths:** 16.2 million (reported, IARC Global Cancer Observatory: https://www.iarc.who.int/news-events/). Denominator: all countries. **2050 Projected annual cancer deaths:** 18.6 million (reported, Lancet Global Burden of Disease Study 2023 / IHME: https://www.healthdata.org/news-events/newsroom/news-releases/lancet-cancer-deaths-expected-rise-over-18-million-2050-increase). This represents 75% increase from 2024 baseline of ~10.4 million deaths. ## United States **2025 US cancer deaths:** 618,120 (reported, American Cancer Society Cancer Statistics 2025: https://pubmed.ncbi.nlm.nih.gov/39817679/). Denominator: US only. **2026 US cancer deaths:** 626,140 (reported, American Cancer Society Cancer Statistics 2026: https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.70043). Denominator: US only. ## Preventability **Preventable cancer share:** 30–50% of all cancer cases preventable by known risk factors (reported, WHO cancer prevention guidance: https://www.who.int/activities/preventing-cancer/). In the US, 40% of cancer cases and nearly 50% of cancer deaths (reported, American Cancer Society recent analysis: https://pressroom.cancer.org/releases). **Modifiable risk factors attribution:** 44% of global cancer deaths in 2019 attributable to behavioral, environmental/occupational, and metabolic risk factors (reported, Tran et al. 2022 GBD analysis in Lancet: https://www.thelancet.com/journals/lancet/article/piis0140-6736(22)01438-6/fulltext). Study examined 34 risk factors across 82 risk-outcome pairings. ## Infection-Preventable Cancers **Infections as cancer cause:** 13% of all new cancer incidence in 2018 (2.2 million cases), reported by de Martel et al. 2020 in Lancet Global Health (https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20)30001-2/fulltext). Primary agents—HPV, HBV, H. pylori, HCV—account for ~90% of infection-attributable cancers. HPV and HBV are vaccine-preventable. ## Not Found Chen et al. 2023 JAMA Oncology cumulative death projections 2020–2050: study estimated economic cost ($25.2 trillion) but did not report total cumulative death count over this period. --- # Orchestrator derivation, 2026-09-16 (inferred from the reported figures above) Annual deaths are interpolated in a straight line between the reported anchors: 9.7 million in 2022 (GLOBOCAN), 16.2 million in 2040 (IARC projection) and 18.6 million in 2050 (Lancet GBD projection). That gives about 11.1 million in 2026 and a cumulative 380 million cancer deaths from 2026 through 2050 inclusive. A deliberately conservative floor that assumes deaths stay flat at the 2022 level for 25 years gives 242 million. Either way, "more than 300 million people will die of cancer between now and 2050" is supported. Saving 100 million lives over that period is 26 percent of the interpolated total, or 41 percent of the flat floor. Both sit below the reported share of cancer deaths attributed to modifiable risk factors (44 percent globally, GBD 2019; 50 percent of US deaths, ACS), and well below the WHO statement that 30 to 50 percent of cancers are preventable. The 100 million figure is therefore a fraction of what prevention is already believed capable of; it does not require eliminating cancer. Infections account for a reported 13 percent of cancer incidence (de Martel 2020), the share that HPV and hepatitis B vaccines already address. The remaining roughly 87 percent is the territory where no preventive vaccine exists, which is the honest scope of the prize. Pitch lines that these figures support, each with its marker: "Cancer will kill more than 300 million people between now and 2050." Inferred, from the reported 2022, 2040 and 2050 figures; conservative. "I want to save 100 million of them." A goal, stated as such; it equals about a quarter to a third of projected deaths, inside the range already attributed to preventable causes. "We have vaccines for the 13 percent of cancers caused by infections. The vaccine era for the other 87 percent has not started." Reported (13 percent, de Martel 2020) and inferred (87 percent).